Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Evidence from a systematic review and meta-analysis of randomized controlled trials suggests that antiresorptive drugs have a protective effect on bone mineral density and bone turnover markers in postmenopausal women with non-metastatic breast cancer receiving aromatase inhibitor therapy.